← Evidence map

ArticleJournal of personalized medicine2024

Switching from Nusinersen to Risdiplam: A Croatian Real-World Experience on Effectiveness and Safety.

Andrej Belančić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38540986